From Study Concept to Regulatory Success
Our services are designed to bridge the gap between research execution and strategic decision-making. We partner with you to ensure your programs meet the highest standards of scientific rigor, regulatory compliance, and operational efficiency.
Research Strategy & Design
-
Study concept development
​​
-
Protocol creation and refinement
​​
-
Statistical planning & analysis consultation
​​
-
Data governance and integrity frameworks​ from the start to ensure scientific, operational, and regulatory success
​
-
Quality by Design (QbD) principles applied from the start to ensure scientific, operational, and regulatory success
​
-
Incorporation of ICH E6(R3) Good Clinical Practice principles into design and oversight to ensure patient safety, data integrity, and regulatory readiness
​
Request Research Strategy & Design Overview
​
Clinical Operations & Oversight
-
Project & site management
​
-
Monitoring & risk-based oversight
​
-
GAP analysis & process optimization
​
-
CRO/vendor evaluation & management
​
-
Vendor oversight practices aligned with ICH E6(R3) to ensure compliance
​
Request Clinical Operations & Oversight Overview
​
Regulatory & Quality Assurance
-
GxP compliance programs
​
-
SOP development and harmonization
​
-
Mock inspections & audit readiness
​
-
Regulatory gap assessments and submission support
​
-
Risk-based quality management grounded in QbD and E6(R3) best practices
​
Request Regulatory & Quality Assurance Overview
​
Investor & VC Support
-
Scientific due diligence for life science investments
​
-
IP/regulatory compliance reviews
​
-
Market readiness and competitive assessments
​
-
Ongoing portfolio monitoring​​
​
Request Investor & VC Support Overview
​
Rescue Projects
Getting Your Program Back on Track
When studies stall, budgets overrun, or regulatory issues arise, Triligent provides the strategic intervention needed to recover momentum. As an RCO, we assess the root cause, stabilize operations, and implement corrective actions that protect data integrity and regulatory viability.
-
Independent audit of study progress and vendor performance
​
-
Recovery plan development with prioritized actions
​
-
CRO/vendor remediation and oversight
​
-
Timeline and budget realignment​​
​
​